BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaDennie T. Frederick, Jennifer A. Wargo, Lindsay P. Newton et al.|Clinical Cancer Research|2013Cited by 938
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of LiteratureKarmela K Chan, Anne R. Bass, Cynthia M. Magro et al.|The Oncologist|2019Cited by 69
Cabozantinib in Patients with Advanced Merkel Cell CarcinomaGuilherme Rabinowits, James A. DeCaprio, Cecilia Lezcano et al.|The Oncologist|2018Cited by 36
Immunohistochemistry for PRAME in DermatopathologyCecilia Lezcano, Klaus J. Busam|American Journal of Dermatopathology|2023Cited by 30